Observational analysis shows improved outcomes in myeloid neoplasm via cytoreductive therapy and imatinib, indicating effective management strategies.
Cardiac involvement in hypereosinophilic syndromes requires multidisciplinary management combining cytoreductive therapy, anticoagulation when thrombus is present, and serial cardiac magnetic resonance. Testing for FIP1L1-platelet-derived growth factor receptor α is disease-defining and therapy-guiding given the marked response to imatinib.
No takes yet. Share an insight, caveat, or question.
Puerto et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: